Pt Hetzer Medical Stock Price To Book
| MEDS Stock | 50.00 0.00 0.00% |
PT Hetzer Medical fundamentals help investors to digest information that contributes to PT Hetzer's financial success or failures. It also enables traders to predict the movement of MEDS Stock. The fundamental analysis module provides a way to measure PT Hetzer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PT Hetzer stock.
MEDS |
PT Hetzer Medical Company Price To Book Analysis
PT Hetzer's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, PT Hetzer Medical has a Price To Book of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The price to book for all Indonesia stocks is 100.0% higher than that of the company.
Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
MEDS Fundamentals
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.12 % | |||
| Shares Outstanding | 1.56 B | |||
| Shares Owned By Insiders | 8.00 % | |||
| Price To Sales | 5.97 X | |||
| Revenue | 43.99 B | |||
| Gross Profit | 53.98 B | |||
| EBITDA | 7.68 B | |||
| Book Value Per Share | 45.78 X | |||
| Number Of Employees | 25 | |||
| Market Capitalization | 231.25 B |
About PT Hetzer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PT Hetzer Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Hetzer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Hetzer Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in MEDS Stock
PT Hetzer financial ratios help investors to determine whether MEDS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDS with respect to the benefits of owning PT Hetzer security.